|
|
|||
| Names | |||
|---|---|---|---|
|
IUPAC name
1-Methyl-3-(2-methylpropyl)-7H-purine-2,6-dione
|
|||
| Other names
3-Isobutyl-1-methylxanthine
|
|||
| Identifiers | |||
|
28822-58-4 |
|||
| 3D model (Jmol) | Interactive image | ||
| ChEBI |
CHEBI:34795 |
||
| ChEMBL |
ChEMBL275084 |
||
| ChemSpider |
3627 |
||
| DrugBank |
DB07954 |
||
| ECHA InfoCard | 100.044.767 | ||
| 388 | |||
| KEGG |
C13708 |
||
| PubChem | 3758 | ||
| UNII |
TBT296U68M |
||
|
|||
|
|||
| Properties | |||
| C10H14N4O2 | |||
| Molar mass | 222.3 g/mol | ||
| Appearance | White solid | ||
| Melting point | 199 to 201 °C (390 to 394 °F; 472 to 474 K) | ||
| Solubility | Soluble in ethanol, DMSO, and methanol | ||
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|||
|
|
|||
| Infobox references | |||
IBMX (3-isobutyl-1-methylxanthine), like other methylated xanthine derivatives, is both a:
As a phosphodiesterase inhibitor, IBMX has IC50 = 2–50 μM and does not inhibit PDE8 or PDE9.